Endocrinology/Hormones
Endocrinology/hormone inhibitors are compounds that block the action of hormones or interfere with hormone signaling pathways. These inhibitors are essential for studying the regulation of endocrine systems and for developing treatments for hormone-related diseases, such as diabetes, thyroid disorders, and hormone-dependent cancers. By modulating hormone activity, these inhibitors can help elucidate the complex interactions within the endocrine system. At CymitQuimica, we offer a wide range of high-quality endocrinology/hormone inhibitors to support your research in endocrinology, pharmacology, and medical sciences.
Subcategories of "Endocrinology/Hormones"
- Androgen Receptor(229 products)
- Annexin A(16 products)
- Aromatase(22 products)
- Estrogen/progestogen Receptor(56 products)
- GPR(1 products)
- Glucocorticoid Receptor(166 products)
- LHRH(1 products)
- Opioid Receptor(326 products)
- Prostaglandin Receptor(122 products)
- RAAS(90 products)
- Reductase(50 products)
- Somatostatin(57 products)
- Thyroid hormone receptor(THR)(32 products)
- Vasopressin Receptor(48 products)
Show 6 more subcategories
Found 3371 products of "Endocrinology/Hormones"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
MTI013
MTI013 is a selective inhibitor of SARS-CoV-2 nsp14 Mtase (IC50: 2.98 µM) and an antiviral agent (IC50: 10.33 µM in HCoV-229E infected Huh7 cells). Additionally, MTI013 demonstrates synergistic antiviral effects when used in conjunction with the RdRp inhibitor SHEN26.Formula:C24H26N6O4SColor and Shape:SolidMolecular weight:494.57Emd 52297
CAS:Emd 52297 is an inhibitor of renin.Formula:C39H59N11O7Purity:98%Color and Shape:SolidMolecular weight:793.96AKR1C3-IN-5
AKR1C3-IN-5 inhibits AKR1C3, key in prostate/breast cancers, with MCF-7 cell IC50 of 9.6 μM.Formula:C34H44N2O7Color and Shape:SolidMolecular weight:592.72U 80215
CAS:U 80215 is an enzyme-competitive inhibitor.Formula:C42H60N8O6SColor and Shape:SolidMolecular weight:805.04Saprisartan potassium
CAS:Saprisartan potassium is an Angiotensin II Type 1 receptor antagonist and antihypertensive agent.Formula:C25H21BrF3KN4O4SColor and Shape:SolidMolecular weight:649.52NOP agonist-1
CAS:NOP agonist-1 (compound 4) is a nociceptin opioid receptor (NOP) partial agonist that attenuates Parkinsonian disabilities in 6-OHDA hemilesioned rats [1].Formula:C22H34N2Molecular weight:326.52Win 45164
CAS:Win 45164 is an orally active ligand for the glucocorticoid receptor (Glucocorticoid Receptor), exhibiting activity that inhibits the pituitary-adrenal axis. It enhances liver glycogen deposition and thymolysis in adrenalectomized male rats. Additionally, Win 45164 possesses anti-inflammatory properties and is applicable in research related to inflammation and neurological disorders.Formula:C26H27FN2O2Molecular weight:418.503AR ligand-44
CAS:AR ligand-44 is an androgen receptor (androgen receptor) ligand that can be utilized in the synthesis of PROTACs such as [ARD-2051].Formula:C23H24ClN3O2Color and Shape:SolidMolecular weight:409.91AKR1C3-IN-7
AKR1C3-IN-7 (Compound 13) is an effective and selective AKR1C3 inhibitor (IC50=0.19 μM). AKR1C3-IN-7 has antitumor activity.Formula:C24H20N2O4Color and Shape:SolidMolecular weight:400.43ErSO-DFP
ErSO-DFP activates a-UPR, targets ERα+ cancer cells with high selectivity, and effectively reduces MCF-7 tumours.Formula:C20H17F5N2O2Color and Shape:SolidMolecular weight:412.35Phenethyl 4-ANPP
CAS:Phenethyl 4-ANPP is a MOR (μ-opioid receptor) agonist with a structure similar to known opioids.Formula:C27H32N2Color and Shape:SolidMolecular weight:384.56LXT34
CAS:LXT34 (Example 2) is a GPR120 agonist with anti-inflammatory properties. This compound enhances GLP-1 formation in the gastrointestinal tract and improves insulin resistance in macrophages and pancreatic cells. LXT34 is applicable in studies related to inflammatory conditions, such as type 2 diabetes, obesity, and non-alcoholic fatty liver disease.Formula:C18H21NO3SColor and Shape:SolidMolecular weight:331.43THR-β agonist 4
CAS:THR-β agonist 4 is a potent agonist of THR-β.Formula:C16H11Cl2F2N5O6SColor and Shape:SolidMolecular weight:510.26THR-β agonist 5
CAS:THR-β agonist 5 (compound 54) is a potent THR-β agonist, with an EC 50 of <50 nM [1].Formula:C22H23N5O2Color and Shape:SolidMolecular weight:389.45KF-19418
CAS:KF-19418 is a follicle stimulant that directly activates follicles in vitro and promotes hair growth in vivo.Formula:C21H14N4OColor and Shape:SolidMolecular weight:338.36(E/Z)-OT-R antagonist 1
CAS:(E/Z)-OT-R antagonist 1 is a mixture of the E/Z configurations of OT-R antagonist 1. This compound is a novel, potent, selective, non-peptide OT-R antagonist that inhibits oxytocin-induced intracellular Ca2+ activity with an IC50 of 8 nM.Formula:C28H29N3O4Color and Shape:SolidMolecular weight:471.55Ciprokiren
CAS:Ciprokiren, a renin inhibitor by Roche, halts human renin; IC50: 0.07/0.65 nmol/L. Lowers blood pressure in animals. Preclinical development ceased.Formula:C37H55N5O8SColor and Shape:SolidMolecular weight:729.93Androgen receptor antagonist 13
CAS:Androgen receptor antagonist 13 (compound 8a) is an orally active androgen receptor antagonist with an IC50 of 0.20 μM. It is used in prostate cancer research.Formula:C16H15N3O3SColor and Shape:SolidMolecular weight:329.375α-Tetrahydrocorticosterone
CAS:5α-Tetrahydrocorticosterone (5α-HB) is an endogenous steroid that acts as an agonist of the glucocorticoid receptor (GR) and a metabolite of corticosterone. It serves as an effective topical anti-inflammatory agent in vivo. In rat liver cells, it decreases the binding of metabolites to the glucocorticoid receptor-corticosterone and its 5α-reduced metabolites, with a Kd value of 268 nM. 5α-Tetrahydrocorticosterone is applicable in research on inflammatory skin diseases.Formula:C21H34O4Color and Shape:SolidMolecular weight:350.49Salvinorin A Propionate
CAS:Salvinorin A propionate: partial KOR agonist, Ki=32.6 nM, EC50=4.7 nM; ignores μ/δ/ORL-1, non-opioid receptors; less potent analgesic vs. salvinorin A.Formula:C24H30O8Color and Shape:SolidMolecular weight:446.49PROTAC Androgen receptor degrader-1
CAS:PROTACAndrogen receptor degrader-1 (Ex.14) is a PROTAC degrader targeting the androgen receptor, with a DC50 of 6 nM. This compound is applicable in prostate cancer research.Formula:C43H48ClN9O2Color and Shape:SolidMolecular weight:758.35AKR1C3-IN-8
AKR1C3-IN-8 (Compound 5) is an effective and selective AKR1C3 inhibitor (IC50=0.069 μM). AKR1C3-IN-8 has antitumor activity.Formula:C23H20N4O3Color and Shape:SolidMolecular weight:400.43GSK866
CAS:GSK866 is a selective glucocorticoid receptor agonist (SEGRA).Formula:C23H21Cl2F4N5O3Color and Shape:SolidMolecular weight:562.34GW856464
CAS:GW856464 is an antagonist of MCHR1. It is utilized in research related to cardiovascular diseases and obesity.Formula:C23H20ClN3O3SColor and Shape:SolidMolecular weight:453.9421-Deacetoxy deflazacort
CAS:<p>21-Deacetoxy deflazacort is a dehydrogenated derivative of Deflazacort, which is a glucocorticoid. As an inactive precursor, Deflazacort rapidly converts into the active metabolite, 21-Desacetyldeflazacort. This compound serves as both an anti-inflammatory and immunosuppressive agent.</p>Formula:C23H29NO4Color and Shape:SolidMolecular weight:383.48Androgen receptor antagonist 11
CAS:Androgen receptor antagonist 11 (compound N29) is a selective, orally available antagonist.Formula:C20H19F3N4O3SColor and Shape:SolidMolecular weight:452.45Sob-AM2
CAS:Sob-AM2 is an effective substrate targeting the fatty acid amide hydrolase (FAAH) expressed in the brain, with a Km of 1.3 μM. It delivers higher concentrations of Sobetirome to the central nervous system at minimal peripheral systemic doses, thereby activating the central thyroid hormone receptor β (TRβ).Formula:C21H27NO3Color and Shape:SolidMolecular weight:341.44EN171
CAS:EN171, a covalent ligand, selectively binds to C38 and C96 on 14-3-3, intensifying 14-3-3's interactions with ERα, YAP, and TAZ. This action impairs both estrogen receptor and Hippo pathway transcriptional activities. Beyond serving as a molecular glue to augment native protein interactions, EN171 also functions as a covalent recruiter for 14-3-3 in heterobifunctional molecules. This facilitates the sequestration of nuclear neo-substrates, such as BRD4 and BLC6, into the cytosol.Formula:C17H22N2OColor and Shape:SolidMolecular weight:270.37MB-07344 sodium
"MB-07344 sodium is a TR-β agonist with a 2.17 nM Ki, boosts Atorvastatin's cholesterol-lowering effects in various animals."Formula:C19H25NaO5PPurity:98%Color and Shape:SolidMolecular weight:387.36Fonsartan free acid
CAS:Fonsartan: Angiotensin receptor blocker, halts angiotensin II effects on rat vascular cells.Formula:C26H32N4O5S2Purity:98%Color and Shape:SolidMolecular weight:544.69BNTX maleate
CAS:δ1 opioid receptor antagonistFormula:C31H31NO8Purity:98%Color and Shape:SolidMolecular weight:545.58Daeatal
CAS:Dynorphin A ethylamide (1-9), the opioid activities were examined in the bioassays.Formula:C56H93N19O10Purity:98%Color and Shape:SolidMolecular weight:1192.46σ1 Receptor/μ Opioid receptor modulator 2
CAS:Compound 4x, also known as σ1 Receptor/μOpioid receptormodulator 2, acts as a μOR agonist and a σ1R antagonist, exhibiting a potent μOR EC50 of 0.6 nM and strong σ1R inhibitory activity (Ki: 363.7 nM). It demonstrates significant analgesic effects in various pain models.Formula:C23H31N3OMolecular weight:365.51OSU-ERb-12
CAS:OSU-ERb-12 is an ERβ agonist that suppresses ovarian cancer cell proliferation both in vitro and in vivo, and decreases the expression of Snail [1] [2].Formula:C15H30B10O2Color and Shape:SolidMolecular weight:350.51BU72
CAS:BU72 is a potent, long-lasting agonist for μ and κ opioid receptors, with partial agonistic activity at the δ opioid receptor (EC50 values of 0.054, 0.033, and 0.58 nM, respectively). It provides strong, enduring analgesic effects primarily mediated through μ opioid receptors. BU72 also exhibits a prolonged duration of activity and can partially reverse morphine-induced analgesia. It is applicable in studies of opioid dependence.Formula:C28H32N2O2Color and Shape:SolidMolecular weight:428.57Amoitone B
CAS:Amoitone B, a cystosporone B derivative, functions as an NR4A1 agonist and exhibits anticancer activity [1].Formula:C22H34O5Color and Shape:SolidMolecular weight:378.5(Rac)-Fidarestat
CAS:(Rac)-Fidarestat ((Rac)-SNK 860) is the racemic form of Fidarestat, functioning as a potent inhibitor of the enzyme aldose reductase.Formula:C12H10FN3O4Color and Shape:SolidMolecular weight:279.224Riminkefon
CAS:Riminkefon is a kappa opioid receptor agonist .Formula:C38H57N7O6Color and Shape:SolidMolecular weight:707.9Mu opioid receptor antagonist 8
CAS:<p>Muopioid Receptor Antagonist 8 (368) serves as an antagonist to the μ-opioid receptor, significantly inhibiting the activation of Gi induced by met-enkephalin at the µOR.</p>Formula:C36H35N3O4SColor and Shape:SolidMolecular weight:605.756β-Naltrexol
CAS:6β-Naltrexol is a peripherally selective opioid antagonist that reduces constipation from opioids while minimizing central nervous system effects.Formula:C20H25NO4Purity:99.933%Color and Shape:SolidMolecular weight:343.42KR31173
CAS:KR31173 is an AT1 antagonist with an IC50 of 3.27 nM. When labeled with the 11C isotope, KR31173 can be used as a tracer for positron emission tomography (PET). In mice, KR31173 exhibits favorable biodistribution and pharmacological characteristics. It selectively binds to organs in CD-1 mice known to have a high density of AT1 angiotensin receptors.Formula:C31H30N8O2Color and Shape:SolidMolecular weight:546.62DS34942424
DS34942424 is an orally potent analgesic which did not exhibit mu opioid receptor agonist activity.Formula:C15H17FN2OColor and Shape:SolidMolecular weight:260.31Mu opioid receptor antagonist 5
Compound NAP: MOR antagonist, crosses blood-brain barrier, EC50: 1.14 nM, Ki: 0.37 nM, useful for OUD research.Formula:C26H29N3O4Color and Shape:SolidMolecular weight:447.53GPR84 antagonist 1
GPR84 antagonist 1 is a highly selective, high-affinity competitive antagonist of human GPR84.Formula:C26H22N4O2Color and Shape:SolidMolecular weight:422.48Mopivabil
Mopivabil is the angiotensin II receptor antagonist[1].Formula:C14H20O3Color and Shape:SolidMolecular weight:236.31Mepixetil
Mepixetil is a potent angiotensin II receptor antagonist[1].Formula:C12H18N2O3Color and Shape:SolidMolecular weight:238.28JTP-117968
CAS:JTP-117968: Non-steroidal SGRM, glucocorticoid receptor modulator, IC50 = 6.8 nM, offers better inhibitory/activatory balance.Formula:C31H31F3N2O2Color and Shape:SolidMolecular weight:520.59Anticancer agent 257
CAS:Anticanceragent 257 (compound of formula (I)) is an anticancer agent that regulates Nur77 and Nurr1.Formula:C15H9Cl2N3Color and Shape:SolidMolecular weight:302.1585α-reductase-IN-1
CAS:5α-reductase-IN-1 is a potent inhibitor of the enzyme 5α-reductase.Formula:C31H37NO5Purity:98%Color and Shape:SolidMolecular weight:503.63ERα degrader 5
ERα degrader 5 is an orally active, selective estrogen receptor (ER) reducer that acts on ERα (EC50: 1.1 nM). ERα degrader 5 shows anti-tumour effects in vivo.Formula:C29H25F4N3O2SColor and Shape:SolidMolecular weight:555.59AR antagonist 4
AR antagonist 4 (Compound 67-b) is an orally active androgen receptor (AR) antagonist that acts on wild-type AR (IC50: 246.6 nM).Formula:C29H36N4OColor and Shape:SolidMolecular weight:456.62NSC 645827
CAS:NSC 645827 is an inhibitor of NAD(P)H:quinone oxidoreductase 1 (NQO1), with an IC50 of 0.7 μM.Formula:C17H17N5O2Color and Shape:SolidMolecular weight:323.349DS69910557
DS69910557: potent hPTHR1 antagonist, IC50 0.08 μM, oral, for hyperparathyroidism & osteoporosis research.Formula:C32H33Cl2FN4O3Color and Shape:SolidMolecular weight:611.53SB-612111 hydrochloride
SB-612111 is a potent ORL-1 antagonist, with high affinity (Ki: 0.33 nM) and µ-receptor activity (Ki: 57.6 nM), blocking Nociceptin-induced pain.Formula:C24H30Cl3NOColor and Shape:SolidMolecular weight:454.86RX 809055AX
CAS:RX 809055AX is a long lasting opioid antagonist at mu and delta receptors.Formula:C29H29ClN2O4Color and Shape:SolidMolecular weight:505MLS000389544
CAS:MLS000389544 is a selective and potent thyroid hormone receptor β (TRβ) antagonist with a methylsulfonyl nitrobenzoic acid structure. It effectively inhibits the interaction between TRβ and steroid receptor coactivator 2 (SRC2).Formula:C20H24N2O7SColor and Shape:SolidMolecular weight:436.479S-HP210
S-HP210: selective GR modulator, blocks NF-κB (IC50: 1.92 μM), non-toxic to mouse fibroblasts.Formula:C22H19N3O2S2Color and Shape:SolidMolecular weight:421.54TUG-2181
CAS:<p>TUG-2181 is an antagonist of GPR84, with an IC50 value of 34 nM. It inhibits reactive oxygen species (ROS) production and IL-8 secretion induced by GPR84 agonists in human neutrophils. TUG-2181 is applicable for research in inflammation and fibrosis.</p>Formula:C21H27NO4Color and Shape:SolidMolecular weight:357.443CI 992
CAS:CI 992 is a novel potent inhibitor of primate renin.Formula:C33H52N6O7S2Color and Shape:SolidMolecular weight:708.93BW 443C
CAS:BW 443C is a selective agonist of mu-opioid receptor.Formula:C33H46N10O10Color and Shape:SolidMolecular weight:742.791Mu opioid receptor antagonist 2
Compound 25: potent, selective MOR antagonist, crosses blood-brain barrier (Ki: 0.37 nM, EC50: 0.44 nM), for OUD research.Formula:C25H28N2O4SColor and Shape:SolidMolecular weight:452.57SB-612111
CAS:SB-612111: potent ORL-1 antagonist, Ki=0.33 nM; μ-, κ-, δ-receptor Ki=57.6, 160.5, 2109 nM; blocks nociceptin's pain effect.Formula:C24H29Cl2NOColor and Shape:SolidMolecular weight:418.40BMS-986034
CAS:BMS-986034 is a GPR119 agonist.Formula:C24H24Cl2N6O4Color and Shape:SolidMolecular weight:531.39RJG-2051
CAS:RJG-2051 is a selective covalent inhibitor of aldo-keto reductase family 1 member C3 (AKR1C3), with an IC50 value of 13 nM. It interferes with the metabolism of substrates such as androgens, estrogens, and prostaglandins through AKR1C3. RJG-2051 holds potential for cancer research.Formula:C26H31N5O4SColor and Shape:SolidMolecular weight:509.62Mu opioid receptor antagonist 4
Compound 31: Potent, selective MOR antagonist; crosses blood-brain barrier; Ki & EC50: 0.38 nM; useful for OUD research.Formula:C25H28N2O4SColor and Shape:SolidMolecular weight:452.57Estrogen receptor antagonist 6
CAS:Estrogen receptor antagonist 6 is a potent blocker of estrogen signaling, regulating various biological effects. (Compound 166)Formula:C25H31F3N2O3Color and Shape:SolidMolecular weight:464.52A 74273
CAS:A 74273, a nonpeptidic and renin inhibitor, may be used to treat cardiovascular diseases due to renin inhibition.Formula:C44H74N4O8Purity:98%Color and Shape:SolidMolecular weight:787.08Elacestrant S enantiomer dihydrochloride
Elacestrant (RAD1901) dihydrochloride, an oral ERR degrader, has IC50 of 48 nM (ERα) and 870 nM (ERβ). Its S enantiomer has low activity.Formula:C30H40Cl2N2O2Purity:98%Color and Shape:SolidMolecular weight:531.56MK-6913
CAS:MK-6913 is a potent and selective agonist of estrogen receptor β.Formula:C25H27N3O2Purity:98%Color and Shape:SolidMolecular weight:401.5CCG258747
CAS:CCG258747 is a novel, selective inhibitor of the GRK2 subfamily.Formula:C28H27FN4O4Color and Shape:SolidMolecular weight:502.54Sunobinop
CAS:Sunobinop (S 117957) is an opioid receptor-like orphan receptor (ORL1) modulator.Formula:C26H33N3O3Color and Shape:SolidMolecular weight:435.56GPR84 antagonist 3
CAS:Potent GPR84 antagonist 3 (compound 42), pIC50 8.28, inhibits GTPγS, with good pharmacokinetics.Formula:C29H27N5OColor and Shape:SolidMolecular weight:461.56(S)-MCOPPB
CAS:(S)-MCOPPB is the S-enantiomer of MCOPPB, an orally active selective agonist for the Nociceptin/Orphanin FQ-Receptor. It inhibits signal transduction in mouse brain NOP receptors and is utilized in anxiety disorder research.Formula:C26H40N4Color and Shape:SolidMolecular weight:408.623JNJ-1250132
CAS:JNJ-1250132 is a steroidal progesterone receptor modulator that inhibits binding of the receptor to DNA in vitro.Formula:C33H41NO4Color and Shape:SolidMolecular weight:515.68rel-SB-612111 hydrochloride
CAS:NOP receptor antagonistFormula:C24H30Cl3NOPurity:98%Color and Shape:SolidMolecular weight:454.86TRβ agonist 1
CAS:TRβ Agonist 1, a selective and mutation-sensitive thyroid hormone receptor β (TRβ) agonist, demonstrates an EC50 value of 21 nM.Formula:C29H25FN2O8Color and Shape:SolidMolecular weight:548.52ERRγ agonist-1
ERRγ agonist-1 can be used in neuropsychological disorders research.Formula:C17H21N5OColor and Shape:SolidMolecular weight:311.38Estrogen receptor-agonist-1
CAS:Estrogen receptor-agonist-1 (compound 4e) is an estrogen receptor (ER) agonist that binds to ERα with high affinity.Formula:C24H22N2O2Color and Shape:SolidMolecular weight:370.444SDM25N hydrochloride
CAS:δ receptor antagonistFormula:C26H27ClN2O3Purity:98%Color and Shape:SolidMolecular weight:450.96FSH receptor antagonist 1
CAS:FSH receptor antagonist 1 (compound 10) is a potent antagonist of the G(s) protein-coupled human follicle-stimulating hormone (FSH) receptor. It exhibits an IC50 value of 28 nM in cell lines expressing the human FSH receptor. This compound significantly inhibits follicle growth and ovulation in in vitro mouse models.Formula:C33H32N2O2Color and Shape:SolidMolecular weight:488.619C108297
CAS:C108297: glucocorticoid modulator, combats diet obesity/inflammation, reduces appetite/lipid storage, boosts fat burn.Formula:C30H36FN3O4SPurity:98%Color and Shape:SolidMolecular weight:553.69LNS8801
CAS:LNS8801 is an orally active agonist of the G protein-coupled estrogen receptor (GPER). By activating GPER, LNS8801 mediates downstream signaling pathways, such as promoting cAMP production and activating CREB signaling, which results in antitumor activities like inhibiting tumor cell proliferation, inducing cell differentiation, and enhancing tumor immunogenicity. It is applicable in research across various cancers, such as melanoma, pancreatic cancer, colorectal cancer, and lung cancer, as well as studies exploring the role of GPER in normal physiological and pathological processes.Formula:C21H18BrNO3Color and Shape:SolidMolecular weight:412.277Dazucorilant
CAS:Dazucorilant (CORT113176), a selective non-steroidal GR modulator, has high affinity with a K i <1 nM, useful for neurological research.Formula:C29H22F4N4O3SColor and Shape:SolidMolecular weight:582.57GPR81 agonist 2
CAS:GPR81 agonist 2 is a potent agonist targeting the GPR81 receptor, demonstrating EC50 values of 0.023 µM for hGPR81 and 0.123 µM for hGPR109A, respectively.Formula:C26H27ClN6O5S2Color and Shape:SolidMolecular weight:603.11GLPG0492 (R enantiomer)
CAS:GLPG0492 R enantiomer is the R enantiomer of GLPG-0492, a novel selective androgen receptor modulator.Formula:C19H14F3N3O3Color and Shape:SolidMolecular weight:389.33AVE 0991
CAS:AVE 0991 is a nonpeptide analog of angiotensin-(1-7), a Mas agonist with inhibitory effects on [125I]-Ang-(1-7) and on neuroinflammation in Alzheimer's disease.Formula:C29H32N4O5S2Purity:99.73%Color and Shape:SolidMolecular weight:580.72AP5 sodium
CAS:AP5 sodium: potent oral GPR40 agonist, enhances ligands, may aid type II diabetes research.Formula:C28H27FNNaO4Color and Shape:SolidMolecular weight:483.515Estrone acetate
CAS:Estrone acetate (Hogival) is an estrogen derivative and an activator of estrogen receptors (ER). This compound can enhance breast development, stimulate the secretion of pituitary prolactin, and induce both the proliferation and activation of lactotrophs, evidenced by the reduction in prolactin storage granule size and the increase in the volume density of the rough endoplasmic reticulum and Golgi apparatus. Estrone acetate holds potential for endocrinological research and for investigating the mechanisms by which estrogen influences pituitary function, prolactin regulation, and breast tumor models.Formula:C20H24O3Color and Shape:SolidMolecular weight:312.403ORIC-101
CAS:ORIC-101 is a highly effective and selective glucocorticoid receptor antagonist (EC50: 5.6 nM). It also has anti-cancer activity.Formula:C34H47NO2Purity:98%Color and Shape:SolidMolecular weight:501.74Estrogen receptor antagonist 4
CAS:Estrogen receptor antagonist 4 blocks ER, impacting cell growth and cancer research potential.Formula:C23H29BF4N4O2Color and Shape:SolidMolecular weight:480.31Androstatrione
CAS:<p>Androstatrione is an androgenic compound.</p>Formula:C19H26O3Color and Shape:SolidMolecular weight:302.41Metahexestrol
CAS:Metahexestrol is an inhibitor of the estrogen receptor (E2R) with antitumor activity. It significantly inhibits the proliferation of estrogen receptor-positive MCF-7 human breast cancer cell line with an ED50 of 1.0 μM. Additionally, Metahexestrol shows inhibitory activity in estrogen receptor-negative MDA-MB-231 cell lines, and its antiproliferative effect is not reversed by estrogen, suggesting that its mechanism may be partially independent of the E2R pathway. Metahexestrol is applicable in research on estrogen-dependent breast cancer.Formula:C18H22O2Color and Shape:SolidMolecular weight:270.366GC 14
CAS:GC 14 is a selective thyroid hormone receptor antagonist, with IC50 values of 200 nM and 35 nM for hTRα and hTRβ, respectively.Formula:C26H27NO6Purity:98%Color and Shape:SolidMolecular weight:449.5LIT-001 free base
CAS:LIT-001, a nonpeptide OT-R agonist, enhances mouse autism-like behavior, with EC50=55 nM and Ki=226 nM.Formula:C28H33N7O2SPurity:98%Color and Shape:SolidMolecular weight:531.67Opioid receptor antagonist 1
CAS:<p>Opioid receptor antagonist 1 (Compound 10) is an Orvinol-based antagonist of opioid receptors. It exhibits activity as an antagonist against the analgesic properties of morphine.</p>Formula:C24H29ClF3NO4Color and Shape:SolidMolecular weight:487.94CH5447240
CAS:CH5447240: potent hPTHR1 agonist, treats Hypoparathyroidism, EC50 12 nM, 55% oral bioavailability, raises rat serum calcium.Formula:C26H39N5O4SPurity:98%Color and Shape:SolidMolecular weight:517.68ERβ agonist-1
CAS:ERβagonist-1 (Compound 8) functions as a dual-active selective ERβ agonist (EC50: 46.8 nM) and an AR antagonist (IC50: 1555 nM). By binding to ERβ, it activates its signaling pathways while simultaneously inhibiting AR activity. Retaining selective ERβ agonist activity in mouse models, ERβagonist-1 is applicable in prostate cancer research.Formula:C25H36O2Color and Shape:SolidMolecular weight:368.55ID11916
CAS:ID11916 is an orally active compound functioning as both an androgen receptor (AR) antagonist and a phosphodiesterase 5 (PDE5) inhibitor. It disrupts androgen binding to AR, impedes nuclear translocation, and blocks androgen-dependent transcriptional activity of AR, while simultaneously elevating intracellular cGMP levels by inhibiting PKG activation. Moreover, ID11916 exhibits potent anticancer effects in prostate cancer cell lines VCaP and 22Rv1, as well as in AR-positive breast cancer cell line SK-BR-3.Formula:C29H27F3N8O3SColor and Shape:SolidMolecular weight:624.637AR antagonist 11
CAS:AR antagonist 11 (Compound c2) is a selective androgen receptor antagonist with an IC50 of 0.019 μM. It is also effective against the ARF877L/T878A mutant (IC50: 1.03 μM). Additionally, AR antagonist 11 inhibits LNCaP cell proliferation and decreases PSA protein expression (IC50: 0.54 μM). This compound is applicable in prostate cancer (PCa) research.Formula:C20H17ClN2OColor and Shape:SolidMolecular weight:336.815LEO 134310
CAS:LEO 134310: Selective, non-steroidal GR agonist with 14 nM EC50, for topical skin disease treatment.Formula:C34H40N2O8Color and Shape:SolidMolecular weight:604.69EN1441
CAS:EN1441 is a covalent degrader that targets the androgen receptor (AR) with an EC50 value of 4.2 μM, as well as its truncated variant AR-V7. It selectively and effectively degrades AR and AR-V7 in androgen-independent prostate cancer cells. EN1441 holds potential for research into androgen-independent prostate cancer.Formula:C13H13ClN2O2Color and Shape:SolidMolecular weight:264.708Estrogen receptor antagonist 7
CAS:ER antagonist 7, compound 13, inhibits ERs, halts breast/ovarian cancer cell growth, has anticancer properties.Formula:C23H17N3O4Color and Shape:SolidMolecular weight:399.4AR antagonist 10
CAS:AR antagonist 10 (Compound Y5) is a potent, orally active androgen receptor (AR) antagonist with an IC50 value of 0.04 μM. It demonstrates a dual mechanism of action: antagonizing AR by disrupting AR dimerization and inducing AR degradation through the ubiquitin-proteasome pathway. This compound shows excellent activity against various resistant AR mutants and effectively inhibits the growth of LNCaP xenograft tumors. AR antagonist 10 is applicable for research in resistant prostate cancer.Formula:C18H17ClN4O3SColor and Shape:SolidMolecular weight:404.871PBPE hydrochloride
CAS:PBPE hydrochloride is a derivative of tamoxifen and functions as a selective ligand for antiestrogen binding sites (AEBS). The binding affinity (Ki) of PBPE hydrochloride and MBPE to AEBS is 8.79 nM and 17.57 nM, respectively.Formula:C19H24ClNOColor and Shape:SolidMolecular weight:317.853Estrogen receptor modulator 11
CAS:Estrogen receptor modulator11 (Compound 27) is a tetrahydroisoquinoline derivative. It exhibits affinity for the estrogen receptor (ER), with IC50 values of 285 nM for ERα and 421 nM for ERβ. Estrogen receptor modulator11 does not demonstrate antagonist activity in MCF-7 cell assays.Formula:C21H18FNOColor and Shape:SolidMolecular weight:319.372Bromadoline
CAS:Bromadoline is an opioid compound that exhibits anti-nociceptive properties in rodents.Formula:C15H21BrN2OColor and Shape:SolidMolecular weight:325.244Triisopropyl phosphate
CAS:Triisopropyl phosphate inhibits TFF1 and EGR3 gene expression and exhibits anti-estrogenic activity by suppressing Estradiol-induced proliferation of MCF-7 cells, with an EC50 of 341 μM. Additionally, Triisopropyl phosphate reduces estrogen response element (ERE)-stimulated luciferase activity in MVLN cells, with an EC50 of 900 μM.Formula:C9H21O4PColor and Shape:SolidMolecular weight:224.234KNT-127
CAS:KNT-127 is an agonist of δ-Opioid receptor.Formula:C24H24N2O2Purity:98%Color and Shape:SolidMolecular weight:372.46AP5
CAS:AP5: GPR40 agonist, positive allosteric modulator; rat hIP1 EC50: 0.49 nM.Formula:C28H28FNO4Purity:98%Color and Shape:SolidMolecular weight:461.52Naltrindole 5′-isothiocyanate
CAS:Naltrindole 5′-isothiocyanate (5'-NTII) is an irreversible delta opioid receptor antagonist that counters the analgesic effects induced by DSLET without altering the effects caused by DPDPE.Formula:C27H25N3O3SColor and Shape:SolidMolecular weight:471.571Urotensin-II receptor antagonist-1
CAS:Urotensin-II receptor antagonist-1 (compound 1) is a human Urotensin II receptor antagonist with low oral bioavailability (F=0-3% in rats) and a Ki of 16 nM in HEK293 cells expressing human recombinant UT receptors. It inhibits cytochrome P450 enzymes (IC50=0.75 μM for CYP2D6; 1.4 μM for CYP3A4), suppresses κ opioid receptors (EC50=3.2 μM), and targets cardiac sodium channels (Ki=2.5 μM).Formula:C25H31Cl2N3OColor and Shape:SolidMolecular weight:460.439Novokinin
CAS:Angiotensin AT2 receptor agonistFormula:C39H61N11O7Purity:98%Color and Shape:SolidMolecular weight:795.975′-Guanidinonaltrindole
CAS:5′-Guanidinonaltrindole (GNTI) is a selective antagonist of the kappa opioid receptor.Formula:C27H29N5O3Color and Shape:SolidMolecular weight:471.551BMS-248360
CAS:BMS-248360: Oral dual hAT1/hETA antagonist with Kis of 10nM & 1.9nM, respectively; treats hypertension.Formula:C36H45N5O5SPurity:98%Color and Shape:SolidMolecular weight:659.84GDC-0927 Racemate
CAS:GDC-0927 Racemate is a degrader of estrogen receptor, is used in the research of ER-related diseases, potently inhibits ER-α activity, with an IC50 of 0.2 nM.Formula:C28H28FNO4Purity:98%Color and Shape:SolidMolecular weight:461.52BNTX
CAS:BNTX (7-Benzylidenenaltrexone) is a selective δ1-opioid receptor antagonist. It competitively counteracts the antisecretory effects of DPDPE, Deltorphin 2, and DAMGO. BNTX is applicable in research focused on antinociceptive effects.Formula:C27H27NO4Color and Shape:SolidMolecular weight:429.508BMS-986118
CAS:BMS-986118 is a GPR40 full agonist targeting type II diabetes, prompting insulin release without hypoglycemia risk.Formula:C25H28ClF3N4O4Purity:98%Color and Shape:SolidMolecular weight:540.96TD-0212
CAS:TD-0212: Oral dual antagonist for AT1 (pKi 8.9) & NEP inhibitor (pIC50 9.2).Formula:C28H34FN3O4SPurity:98%Color and Shape:SolidMolecular weight:527.65TD-0212 TFA
CAS:TD-0212 TFA is an oral AT1 receptor antagonist & NEP inhibitor with pKi 8.9 & pIC50 9.2.Formula:C30H35F4N3O6SPurity:98%Color and Shape:SolidMolecular weight:641.67GNTI dihydrochloride
CAS:κ opioid receptor antagonistFormula:C27H30ClN5O3Purity:98%Color and Shape:SolidMolecular weight:508.01J-113397
CAS:J-113397 is a potent and selective NOP receptor antagonist (IC50 = 2.3 nM).Formula:C24H37N3O2Purity:98%Color and Shape:SolidMolecular weight:399.57PD 134922
CAS:PD 134922 is a HIV-1 protease inhibitors. Inactivation of the protease prevents infectious virion formation.Formula:C37H61N5O7SPurity:98%Color and Shape:SolidMolecular weight:719.97SC13
CAS:SC13, a novel mitragynine analog, exhibits low-efficacy agonism at Mu opioid receptors and provides antinociception while minimizing adverse effects.Formula:C26H30N2O5Color and Shape:SolidMolecular weight:450.53L 365209
CAS:L 365209 is an oxytocin antagonist.Formula:C40H50N8O6Purity:98%Color and Shape:SolidMolecular weight:738.88Mu opioid receptor antagonist 3
Potent, selective MOR antagonist (compound 26); crosses blood-brain barrier. Ki: 0.24 nM, EC50: 0.54 nM; for studying OUD.Formula:C25H28N2O4SColor and Shape:SolidMolecular weight:452.57AT1R antagonist 2
AT1R antagonist 2 is a potent AT1R selective ligand with good AT1R affinity (Ki: 26 nM).Formula:C29H37N5O4S2Color and Shape:SolidMolecular weight:583.77A4B17
A4B17 is an inhibitor of androgen receptor N-terminal with potential for androgen-responsive prostate cancer treatment.Formula:C14H7F4NSColor and Shape:SolidMolecular weight:297.27ER degrader 10
CAS:<p>ER degrader 10 (Compound 51) is an orally active estrogen receptor (ER) selective degrader and antagonist, with a DC50 of 0.43 nM and an IC50 of 0.56 nM. It inhibits the proliferation of ER-positive cells, with an IC50 ranging from 0 to 15 nM. ER degrader 10 exhibits weak inhibitory activity on the hERG channel, with an IC50 greater than 40 μM. It has blood-brain barrier permeability, with a brain/plasma ratio (Kp) of 3.05. In mouse models, ER degrader 10 demonstrates antitumor activity.</p>Formula:C28H29F2NO3SColor and Shape:SolidMolecular weight:497.597Allyphenyline oxalate
CAS:<p>The pKi values of Allyphenyline oxalate (compound 9) for the α2-adrenergic receptor subtypes α2A, α2B, and α2C are 7.24, 6.47, and 7.07, respectively.</p>Formula:C16H20N2O5Color and Shape:SolidMolecular weight:320.34BU09059
CAS:BU09059 is a potent, selective, short-acting antagonist of the κ-opioid receptor (KOR).Formula:C28H37N3O5Purity:98%Color and Shape:SolidMolecular weight:495.61Naldemedine tosylate
CAS:Naldemedine (S-297995) tosylate, a PAMORA, targets μ-, δ-, κ-opioid receptors, aiding OIC research, may bind to SARS-CoV2's 3CL pro.Formula:C39H42N4O9SColor and Shape:SolidMolecular weight:742.84LX1
CAS:LX1, an anti-prostate cancer compound, specifically targets the androgen receptor (AR), AR variants, and the steroidogenic enzyme AKR1C3. It inhibits AKR1C3's enzymatic function, decreases the conversion of androstenedione to testosterone, and reduces the expression of both AR and AR-V7, subsequently downregulating their target genes. Additionally, LX1 is effective in overcoming tumor cell resistance to Enzalutamide, and when combined with Enzalutamide, it further suppresses tumor growth.Formula:C22H15F6NO2Color and Shape:SolidMolecular weight:439.35Androgen receptor degrader-5
CAS:Androgen receptor degrader-5 (compound 14k) demonstrates superior capabilities, specifically in androgen receptor degradation and antiproliferative activity, showcasing its promising properties.Formula:C29H25F4N5O2Color and Shape:SolidMolecular weight:551.53FL442
CAS:FL442 is an Androgen Receptor (AR) modulator. This compound exhibits potent inhibitory effects in AR-dependent prostate cancer cells, showing similar suppression efficiency to the traditional antiandrogen drugs Bicalutamide and Enzalutamide. It also maintains antiandrogen activity against the Enzalutamide-resistant AR mutant F876L. The pharmacokinetic properties of FL442 in mice reveal a longer half-life (8 hours), excellent targeting (prostate tissue), and metabolic stability. Additionally, it is effective at inhibiting LNCaP tumor growth at low plasma concentrations (30 ng/mL).Formula:C15H13F3N2OColor and Shape:SolidMolecular weight:294.27LY2066948
CAS:LY2066948 is a selective oral estrogen receptor modulator (SERM) with high affinity for estrogen receptors ERα and ERβ (Ki of 0.51 and 1.36 nM, respectively) and displays potent anti-estrogenic activity. It effectively blocks the increase in uterine weight induced by ethinylestradiol in immature rats. LY2066948 is utilized in the research of uterine fibroids and myomas.Formula:C30H31NO5SColor and Shape:SolidMolecular weight:517.64(+)-JJ-74-138
CAS:(+)-JJ-74-138 is a novel non-competitive androgen receptor (AR) antagonist capable of inhibiting enzalutamide-resistant castration-resistant prostate cancer (CRPC).Formula:C22H22F8N2OSColor and Shape:SolidMolecular weight:514.48Androgen receptor ligand 1
CAS:Androgen receptorligand 1 is a ligand for the androgen receptor (AR). It interacts with the CRBN E3 ligase via a linker to form an AR-PROTAC degrader. This compound is useful in prostate cancer research.Formula:C19H16F4N2OColor and Shape:SolidMolecular weight:364.34OT-R agonist 1 TFA
CAS:OT-R agonist 1 TFA (compound 5) is an oxytocin receptor (OT-R) agonist with an EC50 value of 0.39 nM. It exhibits V1A antagonist activity, with an EC50 value of 2432 nM, and can be utilized in studies related to central nervous system diseases.Formula:C37H40F3N7O7SColor and Shape:SolidMolecular weight:783.82L162389
CAS:L162389 is an angiotensin II receptor antagonist with a balanced affinity for AT1 and AT2 receptor and stimulates the conversion of phosphatidylinositol.Formula:C31H38N4O4SPurity:99.11% - 99.57%Color and Shape:SolidMolecular weight:562.72Cort108297
CAS:Cort108297: selective GR modulator/antagonist, high GR affinity (Ki: 0.45nM), no other steroid receptor affinity.Formula:C26H25F4N3O3SPurity:98.36% - 99.94%Color and Shape:SolidMolecular weight:535.55Ref: TM-T15000
1mg274.00€5mg622.00€10mg908.00€25mg1,415.00€50mg1,882.00€100mg2,745.00€1mL*10mM (DMSO)747.00€ZD 7155 hydrochloride
CAS:ZD 7155 hydrochloride is an angiotensin II receptor type 1 (AT1 receptor) antagonist.Formula:C26H27ClN6OPurity:99.8%Color and Shape:SolidMolecular weight:474.98Ref: TM-T13390
1mg42.00€5mg88.00€10mg135.00€25mg235.00€50mg396.00€100mg635.00€200mg887.00€1mL*10mM (DMSO)90.00€L-371,257
CAS:L-371,257 is a competitive antagonist of oxytocin receptor with pA2 of 8.4 and Ki of 19 nM. L-371,257 shows a Ki of 3.7 nM for vasopressin receptor 1a.Formula:C28H33N3O6Purity:99.79%Color and Shape:SolidMolecular weight:507.58GLPG0974
CAS:GLPG0974 is an antagonist of FFA2/GPR43 with IC50 of 9 nM.Formula:C25H25ClN2O4SPurity:99.8%Color and Shape:SolidMolecular weight:484.99(E/Z)-GSK5182
CAS:GSK5182 is a racemic mix of (E/Z) isomers, a selective ERRγ inverse agonist (IC50: 79 nM), and induces ROS in liver cancer.Formula:C27H31NO3Purity:97.58%Color and Shape:SolidMolecular weight:417.54Ref: TM-T7709
1mg81.00€5mg170.00€10mg274.00€25mg502.00€50mg747.00€100mg1,121.00€1mL*10mM (DMSO)187.00€LSZ-102
CAS:LSZ-102 is an effective and selective degrader of estrogen receptor (IC50 = 0.2 nM) and can be used in studies about ERα positive breast cancer.Formula:C25H17F3O4SPurity:98.56%Color and Shape:SolidMolecular weight:470.46(S)-Mapracorat
CAS:(S)-Mapracorat is a selective and less active agonist of the glucocorticoid receptor.Formula:C25H26F4N2O2Color and Shape:SolidMolecular weight:462.48ML314
CAS:ML314 is a brain-permeable nonpeptide β-inhibin-biased neurotensin NTR1 receptor agonist (EC50: 1.9 μM), a biased neurotensin receptor ligand for methamphetamine abuse that inhibits NTR2 and GPR35.Formula:C24H28N4O3Purity:99.52%Color and Shape:SolidMolecular weight:420.504Mapracorat
CAS:Mapracorat (ZK-245186, BOL-303242X) is a selective glucocorticoid receptor agonist,anti-inflammatory agent for atopic dermatitis and allergic conjunctivitis.Formula:C25H26F4N2O2Color and Shape:SolidMolecular weight:462.48PSN632408
CAS:PSN632408 is an optimized agonist of GPR119 receptors that display similar potency to OEA at both recombinant mouse and human GPR119 receptors (EC50: 5.6 and 7.9 uM, respectively).Formula:C18H24N4O4Purity:98%Color and Shape:SolidMolecular weight:360.41Horse IGF1(Insulin Like Growth Factor 1) ELISA Kit
<p>The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Horse IGF1. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Horse IGF1. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Horse IGF1, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Horse IGF1 in the samples is then determined by comparing the OD of the samples to the standard curve.</p>Rat VLDL(Very Low Density Lipoprotein) ELISA Kit
<p>The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Rat VLDL. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Rat VLDL. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Rat VLDL, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Rat VLDL in the samples is then determined by comparing the OD of the samples to the standard curve.</p>Mouse MDA(Malondialdehyde) ELISA Kit
<p>This assay employs the competitive inhibition enzyme immunoassay technique. The microtiter plate provided in this kit has been pre-coated with Mouse MDA protein. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Mouse MDA. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Mouse MDA in the samples is then determined by comparing the OD of the samples to the standard curve.</p>Relacorilant
CAS:<p>Relacorilant is an oral glucocorticoid receptor antagonist with Ki of 7.2 nM, potential for treating Cushing's syndrome.</p>Formula:C27H22F4N6O3SPurity:98.53% - 99%Color and Shape:SolidMolecular weight:586.56Phosphoramidon Disodium
CAS:Phosphoramidon Disodium (Phosphoramidon Disodium Salt) Salt is a metalloendopeptidase inhibitor, widely used as a biochemical tool.Formula:C23H34N3Na2O10PPurity:98%Color and Shape:SolidMolecular weight:588.4821-Acetoxypregna-1,4,9(11),16-tetraene-3,20-dione
21-Acetoxypregna-1,4,9(11),16-tetraene-3,20-dione is a valuable organic compound for life sciences research [Catalog No.: T67476, CAS No.: 37413-91-5].Formula:C23H26O4Color and Shape:SolidMolecular weight:366.457AZD9496 maleate
CAS:AZD9496 maleate is a highly potent and selective antagonist of the estrogen receptor alpha (ERα), exhibiting an IC50 value of 0.28 nM. This compound, AZD9496 maleate, is an orally bioavailable selective estrogen receptor degrader (SERD).Formula:C29H29F3N2O6Color and Shape:SolidMolecular weight:558.554L-372662
CAS:L-372662 is bioactive chemical.Formula:C33H38N4O6Color and Shape:SolidMolecular weight:586.68Omzotirome
CAS:Omzotirome (TRC150094) is a functional analog of iodothyronines and holds potential for research on hyperlipidemia (WO2008149379).Formula:C19H24N2O3Color and Shape:SolidMolecular weight:328.412ERB-196
CAS:Erb-196 is an estrogen receptor-receptor agonist with non-steroidal selectivity.Formula:C17H10FNO2Purity:98%Color and Shape:SolidMolecular weight:279.27PF-998425
CAS:non-steroidal androgen receptor (AR) antagonistFormula:C14H14F3NOPurity:98%Color and Shape:SolidMolecular weight:269.26GPR109 receptor agonist-2
CAS:Compound 5, a selective GPR109a agonist, exhibits a pEC50 value of 5.53 [1].Formula:C7H10N2O2Color and Shape:SolidMolecular weight:154.17Cebranopadol
CAS:<p>Cebranopadol (GRT6005) is an analgesic NOP and opioid receptor agonist with Kis of 0.9 nM, 0.7 nM, 2.6 nM, 18 nM for human NOP, μ-opioid (MOP), κ-opioid (KOP)</p>Formula:C24H27FN2OPurity:98.32% - 99.78%Color and Shape:SolidMolecular weight:378.48Pamoic acid
CAS:<p>Pamoic acid is the orphan G protein-coupled receptor GPR35 agonist. Pamoic acid activates ERK and beta-arrestin2 and causes antinociceptive activity.</p>Formula:C23H16O6Purity:99.99%Color and Shape:Fine Yellow PowderMolecular weight:388.37SR17018
CAS:<p>SR17018 is an mu-opioid-receptor (MOR) agonist, binding with GTPγS, with an EC50 of 97 nM.</p>Formula:C19H18Cl3N3OPurity:99.89%Color and Shape:SolidMolecular weight:410.72Ceronapril
CAS:Ceronapril (SQ 29852) is an orally active and potent angiotensin-converting enzyme (ACE) inhibitor (IC50 : 36 nM) for the study of dementia and hypertension.Formula:C21H33N2O6PPurity:97.94%Color and Shape:SolidMolecular weight:440.47Ref: TM-T25226
Discontinued productSR14150
CAS:SR14150 is a partial agonist of high-affinity NOP receptor.Formula:C21H30N2OPurity:98%Color and Shape:SolidMolecular weight:326.48Bromadoline maleate
CAS:Bromadoline is an opioid analgesic selective for the μ-opioid receptor.Formula:C19H25BrN2O5Purity:98%Color and Shape:SolidMolecular weight:441.322Tirzepatide acetate
CAS:<p>Cymit Quimica provides this product solely for uses within the scope of any statute or law providing for an immunity, exemption, or exception to patent infringement (“Exempted Uses”), including but not limited to 35 U.S.C. § 271(e)(1) in the United States, the Bolar type exemption in Europe, and any corresponding exception to patent infringement in any other country. It is the sole responsibility of the purchaser or user of this product, and the purchaser or user of this product agrees to engage only in such Exempted Uses, and to comply with all applicable intellectual property laws and/or regulations. The purchaser of this product agrees to indemnify Cymit Quimica against all claims in connection with the performance of the respective commercial agreement (e.g. supply agreement) and possible infringements of intellectual property rights.</p>Purity:Min. 95%MOR agonist-1
CAS:<p>MOR Agonist-1 is a μ-opioid receptor (MOR) agonist noted for its potent analgesic properties and is utilized in research concerning pain and associated</p>Formula:C22H26ClFN2O2Purity:98%Color and Shape:SolidMolecular weight:404.91Estrogen receptor modulator 8
CAS:<p>Estrogen Receptor Modulator 8 (compound 4) is an orally active inhibitor targeting Estrogen Receptor/ERR α with potent efficacy (IC50 = 0.437 nM in MCF-7 cells</p>Formula:C25H24F4N2O2Purity:98%Color and Shape:SolidMolecular weight:460.46ALS-I-41
CAS:ALS-I-41 is a novel, potent and selective antagonist of oxytocin receptor.Formula:C30H38FN3O6SPurity:98%Color and Shape:SolidMolecular weight:587.7
